Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jay Lieberman, MD
Meissa Vaccines, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medpharmics
Phoenix, Arizona, United States
Charles S Plimpton, MDRecruiting - Paradigm Clinical Research
La Mesa, California, United States
Shaun Berger, MDNot, yet, recruiting - the Emory Children'S Center
Atlanta, Georgia, United States
Evan J Anderson, MDRecruiting - Clinical Research Prime
Idaho Falls, Idaho, United States
Jeffrey B Baker, MDNot, yet, recruiting - Medpharmics
Metairie, Louisiana, United States
Robert J Jeanfreau, MDRecruiting - Meridian Clinical Research
Hastings, Nebraska, United States
Daniel J Leonard, MDNot, yet, recruiting - Meridian Clinical Research
Omaha, Nebraska, United States
Brandon Essink, MDRecruiting - Meridian Clinical Research
Binghamton, New York, United States
Frank Eder, MDRecruiting - Aventiv Research
Columbus, Ohio, United States
Samir Arora, MDNot, yet, recruiting - Coastal Pediatric Research
Summerville, South Carolina, United States
Stephen W Stripling, MDNot, yet, recruiting - Panamerican Clinical Research
Brownsville, Texas, United States
Christopher Romero, MDNot, yet, recruiting - Benchmark Research
San Antonio, Texas, United States
Olutola Adetona, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jun 2021
- Primary completion
- 31 Oct 2023
- Completion
- 31 Oct 2023
- Last update posted
- 2 Aug 2022
- Registered enrollment
- 63
- Registry id
- NCT04909021
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.